| Type : |
Journal |
| Internett-koblingen : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=3804 |
|
| Forskerteamet : |
Nablus - An-Najah National University, Faculty of Medicines and Health Sciences |
| Forfattere : |
Zaid Abdel Naser, Assali M, Qaddomi A, Ghanem M, Zaaror Yara Abu. |
| Tittel : |
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets. |
| Nummer : |
Int J Pharm Compound ; 18, 2 : 169-174. 2014 |
|
| Nivå of Evidence : |
|
| fysisk stabilitet : |
|
| kjemisk stabilitet : |
|
| andre metoder : |
|
| Kommentarer : |
|
Lister
 Valsartan
|
 |
 |
 |
 |
400 mg
Valzan® (Pharmacare PLC) |
| xantangummi |
20 mg |
| hydroksypropylcellulose |
20 mg |
| Aerosil® |
110 mg |
| Banansmak |
20 mg |
| Natriumfosfat |
80 mg |
| Titandioksid |
1 mg |
| Jordbærsmak |
110 mg |
| Sukrose |
22,04 g |
| Renset vann |
>> 25 mL |
|
23-27°C |
 |
| 30 |
 |
|
|
|
|
|
400 mg
Valzan® (Pharmacare PLC) |
| xantangummi |
20 mg |
| hydroksypropylcellulose |
20 mg |
| Aerosil® |
110 mg |
| Banansmak |
20 mg |
| Natriumfosfat |
80 mg |
| Titandioksid |
1 mg |
| Jordbærsmak |
110 mg |
| Sukrose |
22,04 g |
| Renset vann |
>> 25 mL |
|
38-42°C |
|
| 30 |
|
|
|
|
|
